Cullinan Therapeutics, Inc.
CGEM
$12.81
-$0.32-2.44%
NASDAQ
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -9.64% | -7.73% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -0.60% | -26.65% | |||
| Operating Income | 0.60% | 26.65% | |||
| Income Before Tax | -0.20% | 27.76% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -0.20% | 27.76% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -0.20% | 27.76% | |||
| EBIT | 0.60% | 26.65% | |||
| EBITDA | 0.61% | 26.68% | |||
| EPS Basic | 0.01% | 27.83% | |||
| Normalized Basic EPS | 0.00% | 27.83% | |||
| EPS Diluted | 0.01% | 27.83% | |||
| Normalized Diluted EPS | 0.00% | 27.83% | |||
| Average Basic Shares Outstanding | -- | 0.10% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.10% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||